SIGN 137 Management of lung cancer
Lung cancer is the second most common cancer in Scotland.
There are approximately 4,800 new cases and 4,000 deaths each
year. Eighty nine per cent of cases occur in patients over 60 years.
Incidence is higher, and survival is poorer, in people of lower socioeconomic status. The greatest risk factor for lung cancer is exposure to tobacco smoke, with about 90% of patients being smokers or ex-smokers.
This guideline replaces SIGN 80. It covers all aspects of the management of patients with small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), and reflects the most recent evidence on diagnostic and staging investigations, surgery, radiotherapy and systemic anti-cancer therapy.
The guideline will be of interest to chest physicians, surgeons,
radiologists, pathologists, medical and clinical oncologists,
pharmacists, public health practitioners, nurses, general
practitioners, palliative care teams ,allied health professionals, patients and carers.